Episode 7: The First Uromigos Prostate Cancer...

In our final episode recorded at APCCC, Louise Emmett joins us to discuss clinical results and mechanisms of PSMA upregulation by enzalutamide. 

Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development in prostate cancer is discussed with a focus on cytopenia toxicity and future direcctions. 

New research on prostate cancer screening and diet. This episode features audio from: The Pros and Cons of Testing PSA Levels for Prostate Cancer Changing a Man’s Diet After a Prostate Cancer Diagnosis Natural Dietary Treatments for Enlarged Prostate BPH Visit the video pages for ...  Show more

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer. 

Today’s episode is part 2 of our prostate cancer series, and will focus on the important details regarding treatment options for castrate sensitive and resistant prostate cancer.

In this episode, Dr Keith Rourke discusses the diagnosis and management of prostate cancer. After listening to this podcast, learners will be able to: discuss early detection of prostate cancer explain what PSA is list the treatment options for prostate cancer in its early and ad ...  Show more